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enni HarveyLeptin, a hormone produced by adipocytes, provides signals to
specific regions of the hypothalamus to control energy
homeostasis. However, the past decade of research has not
only revealed that leptin receptors are widely expressed in the
CNS, but has also identified numerous additional functions for
this hormone in the brain. In particular, there is evidence that
leptin influences neuronal excitability via the activation as well
as trafficking of specific potassium channels in several brain
regions. Leptin-induced alterations in neuronal excitability have
been implicated in the regulation of food intake, reward
behaviour and anti-convulsant effects. A number of studies
have also identified a role for leptin in cognitive processes that
involve activation of leptin receptors in limbic structures, such
as the hippocampus. Indeed, leptin influences hippocampal-
dependent learning and memory, and more recently leptin has
been shown to have anti-depressant properties.
Characterisation of these novel actions of leptin is providing
valuable insights into the role of this hormone in the regulation
of diverse neuronal functions in health and disease.Addresses
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Introduction
It is well established that the adipocyte-derived hormone
leptin plays a fundamental role in the regulation of food
intake and body weight; actions mediated by the acti-
vation of leptin receptors expressed on specific hypo-
thalamic nuclei. However, leptin receptors are also widely
expressed in many extra-hypothalamic brain regions in-
cluding the cortex, hippocampus, brain stem and cerebel-
lum. Moreover, a growing body of evidence indicates that
leptin is a pleiotropic hormone that has diverse actions
throughout the CNS. Here, the recent advances in leptin
neurobiology are reviewed, with particular emphasis on
the role of this hormone in regulating neuronal excit-
ability and cognitive function.
Open access under CC BY license.ww.sciencedirect.comLeptin and its receptors
Leptin is the 16 kDa protein product of the obese (ob)
gene that is predominantly made and secreted by white
adipose tissue and circulates in the plasma at levels
relative to body fat content [1,2]. In addition to acting
on numerous peripheral tissues, leptin can enter the brain
via saturable receptor-mediated transport across the blood
brain barrier [3] or via the cerebrospinal fluid [4]. Leptin
reaches most regions of the brain via the former transport
process [5]. Leptin may also be made and released locally
in the CNS as leptin mRNA and protein have been
detected in some brain regions [6].
Initially the leptin receptor (Ob-R), which is encoded by
the diabetes (db) gene, was isolated from mouse choroid
plexus [7]. Alternate splicing of the db gene generates
multiple variants of Ob-R mRNA and at least six receptor
isoforms (Ob-Ra-f) have been identified [8]. These iso-
forms have identical N-terminal ligand binding domains
but distinct intracellular C-terminal domains. With the
exception of Ob-Re that lacks a transmembrane domain,
the Ob-R isoforms are subdivided into short forms of the
receptor (Ob-Ra, c, d and f) and a long form (Ob-Rb) with
an extended intracellular region (302 residues). Ob-Rb is
the predominant signaling isoform as various motifs
required for the initiation of signaling are contained
within its extended C-terminal domain.
Leptin receptor expression in the CNS
In rodents and humans, leptin receptor mRNA and
protein are highly expressed in hypothalamic brain
regions involved in regulating energy homeostasis in-
cluding the ventromedial hypothalamus, arcuate nucleus
and dorsomedial hypothalamus [9,10]. However, Ob-Rs
are also highly expressed in many extra-hypothalamic
brain regions including the amygdala, cerebellum, hippo-
campus, brain stem and substantia nigra [11]. More
recently genetic reporter systems have identified the
brain regions that express ObRb, and in accordance with
previous in situ hybridisation and immunocytochemical
studies high levels of expression of ObRb were detected
in hypothalamic and extra-hypothalamic brain regions
[12].
Leptin receptor signal transduction
The leptin receptor displays greatest homology with the
class I cytokine receptor superfamily; receptors within
this family lack intrinsic tyrosine kinase activity and
signal via association with janus tyrosine kinases (JAKs;
Ihle, 1995). Leptin binding to Ob-Rb results in the
activation and phosphorylation of JAK2, which enables
recruitment of various downstream signaling moleculesCurrent Opinion in Pharmacology 2007, 7:643–647
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p85 subunit of phosphoinositide 3-kinase (PI 3-kinase)
and STAT (signal transducers and activators of transcrip-
tion) transcription factors. Another target for JAKs is the
adaptor protein Src homology collagen (Shc), which inter-
acts with Grb2, and in turn recruits the Son-of-sevenless
(Sos) exchange protein to the plasma membrane culmi-
nating in the activation of the Ras-Raf-MAPK pathway
[13].
Modulation of hypothalamic neuron
excitability by leptin
Within the hypothalamus, two neuronal subtypes are
key targets for the actions of leptin with respect to its
effects on food intake and body weight: the orexigenic
neuropeptide Y (NPY) and agouti-related protein
(AGRP)-containing neurons, and anorexigenic proopio-
melanocortin (POMC) and cocaine and amphetamine
regulated transcript (CART)-containing neurons,
respectively. Electrophysiological studies have shown
that leptin hyperpolarises glucose-responsive NPY/
AGRP neurons via activation of ATP-sensitive K+ (KATP)
channels [14]; an action likely to result in decreased
action potential firing frequency in NPY/AGRP neurons
[15], a reduction in transmitter output and ultimately
reduced food intake. Opening of KATP channels is rapid
as channel activation occurs within 10 min of leptin
addition. Furthermore, inhibitors of PI 3-kinase prevent
channel activation by leptin thereby implicating
PI 3-kinase in leptin receptor coupling to KATP channels
[14]. In a manner similar to the hypothalamus, leptin also
rapidly inhibits neurons located within the dorsal motor
nucleus of the vagus and the nucleus tractus solitarius via
PI 3-kinase-driven activation of KATP channels [16,17].
It is well documented that PI 3-kinase promotes the
phosphorylation of PtdIns(4,5)P2 into PtdIns(3,4,5)P3.
Indeed, in a hypothalamic cell line, leptin increases
PtdIns(3,4,5)P3 immunoreactivity [18
]. Moreover,
genetic inactivation of PTEN in hypothalamic neurons
has shown that PtdIns(3,4,5)P3-dependent signaling is
pivotal for KATP channel activation [19
]. Functional
inactivation of PTEN by leptin is also reported to
increase PtdIns(3,4,5)P3 levels and promote KATP chan-
nel activation in an hypothalamic cell line [18]. This not
only suggests that the PTEN phosphatase is a novel
component of leptin signaling but also that the excit-
ability of hypothalamic neurons can be controlled by
regulation of this phosphatase by leptin. The lipid pro-
ducts of PI 3-kinase closely associate with the actin
cytoskeleton, and re-organisation of actin filaments plays
a key role in the opening of numerous ion channels.
Indeed, leptin activation of KATP channels in hypothala-
mic neurons [20] and insulinoma cells [21] involves
PI 3-kinase-driven depolymerisation of actin filaments.
However, in these cells it remains to be determined howCurrent Opinion in Pharmacology 2007, 7:643–647the leptin dependent increase in PtdIns(3,4,5)P3 levels
influences actin dynamics.
Leptin regulation of hippocampal excitability
In contrast to its actions on hypothalamic neurons, leptin
inhibits hippocampal neurons via activating large con-
ductance Ca2+-activated K+ (BK), but not KATP, channels
[22]. Although the potassium channels targeted by leptin
in the hippocampus and hypothalamus differ, the sig-
naling pathway underlying their activation by leptin is
analogous as a PI 3-kinase-driven signaling cascade
couples leptin receptors to hippocampal BK channels
[22]. In support of a PI 3-kinase-mediated event in BK
channel activation, exposure of hippocampal neurons to
leptin results in a rapid and highly localised elevation in
the synaptic levels of PtdIns(3,4,5)P3. This in turn pro-
motes re-organisation of actin filaments that ultimately
results in the activation as well as the trafficking of BK
channels to hippocampal synapses [23]. As hippocampal
BK channels are responsible for repolarising action poten-
tials and influence action potential firing rates, this leptin-
dependent sequence of events is likely to have important
implications for hippocampal excitability. Indeed, Shan-
ley et al. [24] demonstrated that leptin has powerful anti-
convulsant properties as demonstrated by its ability to
significantly reduce hippocampal excitability in two dis-
tinct epilepsy models. The effects of leptin have also
been assessed in a penicillin model of epilepsy in the
somatomoter cortex. However, in this brain region leptin
is reported to have pro-convulsant activity [25],
suggesting that there may be regional differences in
the capacity of leptin to influence neuronal hyperexcit-
ability.
In addition to regulating hippocampal excitability by
modulating BK channel function, there is evidence that
leptin evokes a novel form ofNMDA receptor-dependent
long-term depression (LTD) under conditions of
enhanced excitability [26]. The ability of leptin to mark-
edly alter the efficacy of excitatory synaptic transmission
under such conditions indicates that leptin can regulate
hippocampal neuron excitability via both synaptic and
non-synaptic mechanisms. However, in contrast to the PI
3-kinase-dependent events underlying leptin activation
of BK channels, leptin-induced LTD is negatively
regulated by PI 3-kinase and serine/threonine phospha-
tases 1/2A [26], indicating that distinct cellular signaling
mechanisms are involved in these phenomenon.
The effects of leptin on brain reward circuitry
Recently, leptin receptor expression has been detected
onmesolimbic dopamine neurons within the basal ganglia
[27]. Moreover, administration of leptin, either peripher-
ally to anaesthetised rats or acutely to in vitro brain slices,
results in marked attenuation of the firing frequency of
VTA dopaminergic neurons [28], indicating that leptin
plays a role in regulating the mesolimbic dopaminewww.sciencedirect.com
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vesicular somatodendritic stores of dopamine [29],
suggesting that leptin tonically inhibits dopamine
neurons within the VTA leading to a decrease in both
dopamine release and food intake. Although there is
evidence that leptin promotes phosphorylation of STAT3
in VTA dopaminergic neurons [28,30], the precise
cellular mechanisms underlying the direct effects of
leptin on mesolimbic neuron excitability remain to be
determined.
Leptin influences hippocampal-dependent
learning and memory
It is well established that learning and memory is a key
function of the hippocampus. Indeed, one form of synap-
tic plasticity known as long-term potentiation (LTP)
occurs in this brain region; a phenomenon thought to
be a cellular correlate of certain aspects of learning,
memory and habituation. In the hippocampal CA1 region,
N-methyl-D-aspartate (NMDA) receptor-dependent
LTP contributes to the formation of spatial memory
[31]. Recently, several studies have implicated the hor-
mone leptin in hippocampal synaptic plasticity. Indeed,
rodents with leptin receptor mutations (db/dbmice or fa/fa
rats) exhibit impairments in hippocampal LTP and long-
term depression [32] as well deficits in hippocampal-
specific memory tasks [32,33]. Direct administration of
leptin into the hippocampus improves learning and mem-
ory performance [34,35] and facilitates hippocampal LTP
[36]. Furthermore, leptin facilitates the conversion of
short-term potentiation (STP) into LTP [37] and
enhances LTP at hippocampal CA1 synapses [35]. The
synaptic activation of NMDA receptors and a concomi-
tant postsynaptic rise in intracellular Ca2+ are pre-requi-
sites for the LTP induction in the CA1 region [31].
Moreover, several studies have demonstrated that numer-
ous growth factors and hormones can influence hippo-
campal LTP; actions that predominantly occur via
modulation of NMDA receptor function. Similarly, leptin
displays NMDA-enhancing properties as it rapidly facili-
tates both NMDA receptor-dependent synaptic currents
in hippocampal slices from two-week-old to three-week-
old rats and NMDA-induced Ca2+ influx in hippocampal
cultures via activation of PI 3-kinase and MAPK-depend-
ent signaling cascades [37]. Moreover, in Xenopus oocytes
expressing recombinant NMDA receptors, leptin
enhanced currents evoked by maximal, as well as sub-
maximal concentrations of NMDA [38], suggesting that
the density of functional NMDA receptors is increased by
leptin. However, the ability of leptin to modulate NMDA
receptor function may be age-dependent as leptin is also
reported to inhibit, rather than enhance, NMDA-induced
currents in hippocampal slices from six-week-old to sev-
en-week-old rats [35].
Evidence is accumulating that structural changes play a
pivotal role in activity-dependent synaptic plasticity andwww.sciencedirect.comthis process is influenced by various neurotrophins.
Recently, O’Malley et al. [39] demonstrated that leptin
promotes rapid remodeling of hippocampal dendrites, via
a process requiring the synaptic activation of NR2A-
containing NMDA receptors and the MAPK (ERK) sig-
naling cascade. This effect of leptin is associated with the
formation of new synaptic connections as leptin also
rapidly enhanced the density of hippocampal synapses.
Previous studies have shown that the changes in dendritic
morphology evoked by neurotrophins such as BDNF
occur after several hours exposure to these agents. By
contrast, the dendritic remodeling induced by leptin
occurs over a much faster time scale as it is evident within
a matter of minutes. Moreover, the time course of these
leptin-induced changes is similar to the structural changes
reported to occur following the induction of hippocampal
LTP. These findings not only lend further support to the
proposed role for leptin in hippocampal synaptic
plasticity, but also indicate that leptin has the capacity
to rapidly remodel dendrites that in turn may underlie its
effects on hippocampal LTP.
Metabolic disturbance and the development
of neurodegenerative disorders
Several lines of evidence have implicated dysregulation
and/or deficiencies in the leptin system in the cognitive
deficits associated with neurodegenerative disorders such
as Alzheimer’s disease. Indeed reductions in the circulat-
ing levels of leptin have been detected in Alzheimer’s
disease patients [40]. Moreover, leptin is reported to
significantly decrease the levels of amyloid b [41] and
to improvememory performance [34] in transgenicmouse
models of Alzheimer’s disease. It is known that obesity in
humans closely correlates with the development of type
II diabetes. Moreover, cognitive deficits are prevalent in
diabetic patients. As obesity and obesity-linked disorders
such as type II diabetes are associated with leptin resist-
ance at the level of the blood brain barrier [42], it is likely
that CNS insensitivity to leptin plays a role in the cog-
nitive impairments in these individuals.
Leptin is a novel anti-depressant
In addition to its role in hippocampal-dependent learning
and memory, recent studies have demonstrated that
leptin has anti-depressant-like activity. Indeed, exposure
of rodents to stress paradigms, which induce various
behavioural deficits resembling certain aspects of human
depression, results in significant decreases in the circulat-
ing levels of leptin [43]. Moreover, systemic adminis-
tration of leptin reversed the impairments in rewarding
behaviour that occurs in chronically stressed rats; an effect
that mirrors the actions of anti-depressant drugs in similar
animal models. Hippocampal leptin receptors are likely to
be the site of leptin’s anti-depressant actions as admin-
istration of leptin into the hippocampus, but not hypo-
thalamus, evoked anti-depressant-like effects in the
forced swim test. Thus, these data suggest that leptinCurrent Opinion in Pharmacology 2007, 7:643–647
646 Endocrine and metabolic diseasesis a novel anti-depressant and that dysregulation of the
leptin system may be an underlying feature of certain
depressive disorders. This raises the interesting possib-
ility that agents that enhance leptin receptor-driven sig-
naling may be useful therapeutic targets in the treatment
of depression.
Conclusions
Evidence is accumulating that leptin plays a pivotal role
in modulating diverse neuronal functions. Recent studies
have shown that leptin rapidly regulates the excitability
of neurons via potassium channel activation in a number
of brain regions. In addition, transgenic studies combined
with advanced molecular approaches have greatly pro-
gressed our understanding of the complex cellular mech-
anisms coupling leptin receptors to potassium channel
activation as well as the resulting functional outputs. In
other studies, a role for leptin in modulating hippo-
campal-dependent cognitive function has been ident-
ified. Moreover, major advances have been made in the
characterisation of the cellular targets, signaling pathways
and structural changes that underlie the effects of leptin
on these hippocampal-driven processes.
Although the cellular consequences of leptin receptor
activation are becoming well characterised, there are still
gaps in our knowledge of how the neuronal leptin system
functions. For instance, the conditions under which
physiologically relevant concentrations of leptin reach
the extra-hypothalamic brain regions that respond to this
hormone are not clear. Although there is evidence for
leptin mRNA in the brain, it is not known if leptin can be
released from neurons, and if so the processes regulating
the release mechanisms. Many studies have demon-
strated that leptin is an important modulator of
activity-dependent synaptic plasticity and neuronal de-
velopment. Moreover, it is well known that developmen-
tal processes are under the control of various growth
factors and neurotrophins. However, it is not clear if
and how the effects of leptin on synaptic plasticity and
neurodevelopment are influenced by other hormones and
growth factors.
Another important focus of current research is the associ-
ation between obesity-linked leptin resistance and the
development of neurodegenerative disorders such as
Alzheimer’s disease. This, combined with the recent
discovery of the anti-depressant properties of leptin,
may ultimately result in the generation of promising
new therapies to treat a wide spectrum of neurological
conditions.
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